GlassScriptPhysician profile
Abdallah Dlewati
NPI 1609054899
$9,418.25
in general payments reported to CMS, 2019-2025
66 companies · $1,264 in 2025
The $1,264 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,248 · 2020: $846 · 2021: $1,614 · 2022: $1,460 · 2023: $1,496 · 2024: $1,490 · 2025: $1,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,250.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $780.03 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $730.82 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $720.89 | 2019-2025 | Freestyle Libre 3 |
| Amgen INC. | $461.08 | 2019-2025 | Evenity, Prolia, Tepezza |
| Corcept Therapeutics | $452.22 | 2019-2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $449.80 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $352.50 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Radius Health, INC. | $298.16 | 2019-2025 | Tymlos |
| Abbvie INC. | $297.60 | 2019-2025 | Synthroid, Ubrelvy |
| Antares Pharma, INC. | $282.50 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Xeris Pharmaceuticals, INC. | $280.78 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Merck Sharp & Dohme LLC | $275.60 | 2019-2022 | |
| Amarin Pharma, INC. | $218.71 | 2019-2023 | |
| Medtronic, INC. | $204.02 | 2021-2025 | Minimed 780g |
| Amneal Pharmaceuticals LLC | $196.99 | 2019-2025 | Unithroid |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $192.34 | 2021-2025 | |
| Lifescan, INC. | $177.26 | 2019-2023 | |
| Halozyme INC | $165.01 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $160.16 | 2019-2022 | |
| Dexcom, INC. | $155.91 | 2019-2024 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $152.19 | 2022-2024 | Nexletol |
| Insulet Corporation | $137.72 | 2019-2024 | Omnipod |
| Ipsen Biopharmaceuticals, INC | $133.76 | 2019-2023 | Somatuline Depot |
| Alexion Pharmaceuticals, INC. | $118.15 | 2019-2024 | Strensiq |
| Astellas Pharma US INC | $112.71 | 2024-2025 | Veozah |
| Ibsa Pharma INC. | $102.84 | 2019-2025 | Flector, Licart, Tirosint |
| Alvogen INC | $100.44 | 2022-2025 | Teriparatide |
| Pfizer INC. | $96.20 | 2019-2025 | |
| Recordati_rare_diseases_inc. | $84.28 | 2020-2025 | Isturisa, Signifor Lar |
| Horizon Therapeutics Plc | $80.98 | 2019-2023 | Tepezza |
| Becton, Dickinson and Company | $79.98 | 2021-2022 | |
| Mannkind Corporation | $74.77 | 2021-2025 | Afrezza |
| Evoke Pharma, INC. | $74.72 | 2021-2024 | Gimoti |
| Verity Pharmaceuticals INC. | $68.76 | 2024-2025 | Tlando |
| Amphastar Pharmaceuticals, INC. | $68.08 | 2024-2025 | |
| Beta Bionics, INC. | $64.56 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Ascendis Pharma Endocrinology INC | $62.26 | 2025 | Yorvipath |
| Janssen Pharmaceuticals, INC | $58.14 | 2019 | |
| Amryt Pharma Holdings LTD | $52.47 | 2022-2023 | Mycapssa |
| Medtronic Minimed, INC. | $49.76 | 2019-2020 | |
| Cequr Corporation | $47.43 | 2022-2024 | Cequr Simplicity |
| Ascensia Diabetes Care US INC. | $46.68 | 2024-2025 | |
| Embecta Corp. | $46.62 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Clarus Therapeutics INC. | $45.86 | 2021 | |
| Currax Pharmaceuticals LLC | $43.74 | 2021-2022 | |
| Sequel Med Tech, LLC | $43.46 | 2025 | Twiist |
| Zealand Pharma US, INC. | $42.86 | 2021-2022 | |
| Kyowa Kirin, INC. | $39.35 | 2023-2024 | Crysvita |
| Neurocrine Biosciences, INC. | $37.37 | 2025 | |
| Nevro Corp. | $35.74 | 2022 | |
| Acerus Pharmaceuticals Corporation | $34.89 | 2021 | |
| Ferring Pharmaceuticals INC. | $34.58 | 2019-2020 | |
| Acella Pharmaceuticals, LLC | $33.32 | 2024-2025 | NP Thyroid 60 |
| Tolmar, INC. | $31.79 | 2023-2025 | Jatenzo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.64 | 2019 | |
| Companion Medical, INC. | $27.94 | 2020 | |
| Gilead Sciences, INC. | $26.57 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $23.42 | 2019-2021 | |
| Madrigal Pharmaceuticals | $22.91 | 2025 | Rezdiffra |
| Ultragenyx Pharmaceutical INC. | $17.56 | 2021 | |
| Azurity Pharmaceuticals, INC. | $16.96 | 2025 | Azmiro |
| Nalpropion Pharmaceuticals LLC | $15.04 | 2019 | |
| Shire North American Group INC | $14.30 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.45 | 2020 | |
| Valeritas, INC. | $11.78 | 2019 | |
| Theracosbio, LLC | $10.84 | 2024 | Brenzavvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdallah Dlewati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.